Among people with type 2 diabetes, they consistently lower HbA1c and reduce mortality and cardiovascular events
In the meantime, your best options for lowering costs are manufacturer cash-pay programs through NovoCare , savings cards (if you have commercial insurance), and shopping for the most favorable pharmacy pricing
Have you taken a GLP-1 drug
Second, with any short-term agent, durability is the weak point short-term weight loss is common, but the majority of patients regain weight over the following years unless the underlying behavior and physiology are addressed
Study: 16 new obesity drugs could come to market in the next 5 years The GLP-1 market is expected to hit $200 billion by 2031, according to a new study
Impact of glp-1 receptor agonists on hospitalization for heart failure and all-cause death in patients with diabetes with and without heart failure: a real-world study